What are the options of induction treatment of young AML patients who are on CRRT, continuous renal replacement therapy ?

Hypomethylating agent like decitabine and venetoclax will be good options.

C1 decitabine for 10 days and venetoclax for 28 days. Then C2 decitabine for 5 days and venetoclax every 28 days. Bone marrow biopsy should be done on day 21.

There is, however, no strong literature support regarding pharmaco...